Wednesday, March 08, 2017 8:44:33 PM
Among the key things that sold me on the company is their leadership team, which features blue-chip business executives and top-notch scientists and chemists. These guys know cannabis top to bottom and should be able to produce unique marketable products after successful clinical trials.
That said, everyone needs to bear in mind that Veritas, like many other small start-ups, is still a very early-stage cannabis company. They are still years away from earning significant profits because of the lengthy, intensive nature of human clinical trials. The good news is that this is one of the rare companies that I believe you can count on to actually achieve their long-term goals, and when that does happen the company will be worth hundreds of millions, not the US$10 million they're worth today.
Despite being early stage, there is still a lot of room for Veritas stock to go up in price in the near term. Veritas is rather overlooked and people will discover it as future news about milestones and getting government approvals is achieved. You and I are in on the ground floor, but there is still time for others to join us before the scope and credibility of the company is demonstrated.
Obviously, Marapharma is a company that recognized Veritas's stellar leadership when they made a major investment in the organization (which makes Marapharma a good investment as well).
Bottom line, unlike many small cannabis companies, Veritas will actually prove to be a huge winner in the coming years. I am willing to be patient and keep investing on the dips like we had today. It's good to see you are just as excited as I am, so keep the faith and keep posting those news updates!
Recent VRT News
- Vertiv to Participate in Upcoming Conferences • Business Wire • 04/29/2024 12:00:00 PM
- U.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures Trading • IH Market News • 04/24/2024 11:31:20 AM
- Vertiv Reports 60% Organic Orders Growth, 8% Net Sales Growth in First Quarter; Updates Full Year 2024 Outlook • Business Wire • 04/24/2024 09:55:00 AM
- Vertiv Announces Date of First Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/10/2024 12:00:00 PM
- Vertiv Unveils End-to-End AI Power and Cooling Solutions to Simplify Data Center Infrastructure Selection and Deployment in North America • Business Wire • 04/04/2024 09:36:00 PM
- Vertiv Joins the NVIDIA Partner Network • Business Wire • 03/18/2024 10:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:55:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:33:12 PM
- Vertiv Declares Quarterly Dividend • Business Wire • 03/07/2024 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:01:32 AM
- Vertiv to Participate in Upcoming J.P. Morgan Industrials Conference • Business Wire • 03/04/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 12:45:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 11:02:03 AM
- Vertiv Reports Strong Fourth Quarter Results and Provides Full Year 2024 Outlook • Business Wire • 02/21/2024 10:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:03 PM
- Vertiv Announces Date of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • Business Wire • 01/31/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:31:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:28:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:27:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 12:26:32 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM